EQS-News
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
- Mainz Biomed organizes HALLO DOC! event on March 20, 2024 in Berlin.
- Event focuses on innovations in colorectal cancer treatment.
- Features expert insights, patient perspective, interactive sessions, and networking opportunities.
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment |
BERKELEY, US – MAINZ, Germany – March 19th 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, will be organizing the HALLO DOC! event, informing about colorectal cancer, cutting-edge research, new treatment modalities and holistic therapeutic approaches. This event will take place on March 20, 2024, in Berlin, Germany, aligning with the Colorectal Cancer Awareness Month.
HALLO DOC! comes at a critical time as the incidence of colorectal cancer increases alarmingly, particularly among the youth, emphasizing the necessity for effective prevention, early detection, and the avoidance of recurrence. Mainz Biomed has organized this event to shed light on new diagnostic methods, the importance of a comprehensive treatment approach, and the latest advancements in colorectal cancer research.
Event Highlights:
- Expert Insights: Keynote presentations by renowned experts, including Prof. Dr. Guido Schumacher, Priv. Doz. Dr. med Annika Kurreck, Prof. Dr. Ingo Froböse, and Priv. Doz. Dr. Severin Daum, offering invaluable insights into modern colorectal cancer treatment methods, the critical role of early detection, and personalized medicine.
- Patient Perspective: A moving account by Jule Blöhmer, a young colorectal cancer survivor, aiming to inspire and inform others about the journey through diagnosis, treatment, and recovery.
- Interactive Sessions: Engaging Q&A sessions with the audience, both on-site and streaming online, facilitating a deeper understanding and discussion about colorectal cancer.
- Innovative Research: Presentation of groundbreaking studies on the role of the microbiome and molecular markers in colorectal cancer prevention and treatment, highlighting Mainz Biomed's contributions to the field.
- Networking Opportunity: A "Get Together" session to conclude the event, allowing for personal interactions among attendees, speakers, and professionals.
Attendance: